Xuejuan Jin

Correction to: Histone Lactylation–Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation

Liwei Liu, Jinyan Zhang, Zhen Dong, Yikai Cui et autres

Validation of the 2022 ACR/EULAR classification criteria for eosinophilic granulomatosis with polyangiitis in a Chinese cohort

Yun Liu, Minglang Zhan, Sheng-An Chen, Xuejuan Jin et autres

cn (code pays fourni par la source)

Histone Lactylation–Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation

Liwei Liu, Jinyan Zhang, Z H Dong, Yikai Cui et autres

cn, us (code pays fourni par la source)

Nationwide Implementation of Heart Failure Therapies: National Heart Failure Center Accreditation Program (HF-CAP) in China

Jingmin Zhou, Xuejuan Jin, Yamei Xu, Zhonglei Xie et autres

cn, hk, fr (code pays fourni par la source)

Global, regional, and national burden of vascular intestinal disorders, 1990–2021 and predictions to 2035: A systemic analysis for the Global Burden of Disease Study

Zike Chen, Mengyan Chen, Chen Wang, Xuejuan Jin et autres

cn (code pays fourni par la source)

Effectiveness of Upper Gastrointestinal Endoscopic Submucosal Dissection Using a New Therapeutic Thin Scope, EG-840TP, for Patients with Pharyngeal and Esophageal Stricture

Yoshiro Ogata, Waku Hatta, Takashi Koike, Y. Hatayama et autres

Cardiac secreted HSP90α exacerbates pressure overload myocardial hypertrophy and heart failure

Le Pan, Chenxing Huang, Xuejuan Jin, Jian Wu et autres

cn, jp (code pays fourni par la source)

Corrigendum to “FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a” [Redox Biol. 70 (2024) 103081]

Miyesaier Abudureyimu, Xuanming Luo, Lingling Jiang, Xuejuan Jin et autres

cn (code pays fourni par la source)

FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a

Miyesaier Abudureyimu, Xuanming Luo, Lingling Jiang, Xuejuan Jin et autres

cn (code pays fourni par la source)

Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis. Reply

Jinghua Wang, Xiufang Kong, Xuejuan Jin, Lindi Jiang

cn (code pays fourni par la source)

Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry

Jingmin Zhou, Xuejuan Jin, Jun Zhou, Yamei Xu et autres

cn, se (code pays fourni par la source)

Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study

Jinghua Wang, Xiufang Kong, Lili Ma, Zhenqi Ding et autres

cn (code pays fourni par la source)